drugset
drugset / Trial / NCT02372474

"It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure

NCT02372474 ↗

Phase 1/2 Completed 112 enrolled Al-Azhar University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this work is to evaluate the therapeutic potential of Autologous Mesenchymal sc (MSC) therapy in women suffering from POF.

Timeline

Start
2012-03
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Stem Cell Cell therapy — Other

Indications

primary ovarian failure